Alcon Receives Health Canada Approval for Unity VCS

Alcon announced that Unity Vitreoretinal Cataract System (VCS) has received Health Canada approval.

Unity VCS is designed to deliver enhanced workflow efficiencies over Alcon’s current leading systems, Constellation Vision System for vitreoretinal and combined procedures, and Centurion Vision System with Active sentry for cataract surgery.

Unity VCS leverages a novel phacoemulsification modality to deliver up to two times faster nucleus removal with 40% less energy* into the eye,[1] and a first-of-its-kind phaco handpiece that estimates temperature at the incision site.[3] In vitreoretinal advancements, the new technology offers cutting speeds of up to 30,000 cuts per minute, the world’s fastest vitrectomy probe [2,3]. The platform offers surgical stability and efficiency with a unique proprietary fluidics system.[3]

"Unity VCS builds on Alcon’s expertise in surgical equipment with pioneering innovations for vitreoretinal and cataract surgery—driving advancements from cutting speeds to fluidics management, to ergonomics and workflow. We are thrilled to bring this latest breakthrough technology, Unity VCS, to Canadian clinics in 2026," Jeroen Bastemeijer, General Manager, Alcon Canada, said in a company news release. 

Alcon received FDA 510(k) clearance for the Unity VCS in June 2025.